Tomás C. Tempesti
YOU?
Author Swipe
View article: Biocompatible Zn‐Phthalocyanine/Gelatin Nanofiber Membrane for Antibacterial Therapy
Biocompatible Zn‐Phthalocyanine/Gelatin Nanofiber Membrane for Antibacterial Therapy Open
In this study, the fabrication and characterization of Zn‐phthalocyanine/gelatin nanofibrous membranes is reported using the electrospinning technique. The membranes exhibit a homogeneous distribution of Zn‐phthalocyanine within the gelati…
View article: An Alternative Pathway for the Synthesis of Glycerol Phenylbutyrate
An Alternative Pathway for the Synthesis of Glycerol Phenylbutyrate Open
Hyperammonemia is a life‐threatening condition which can affect patients at any age. In pediatric patients, hyperammonemia can be caused by various acquired or inherited disorders such as urea cycle deficiencies or organic acidemias. Glyce…
View article: Photophysical and photodynamic analysis of different formulations of riboflavin
Photophysical and photodynamic analysis of different formulations of riboflavin Open
Background: Riboflavin (Rb) has been used in the ophthalmological procedure known as corneal cross-linking (CXL). Pathologies requiring this treatment include keratoconus, corneal ectasia, and infectious keratitis. Rb is instilled via diff…
View article: Current Phthalocyanines Delivery Systems in Photodynamic Therapy: An Updated Review
Current Phthalocyanines Delivery Systems in Photodynamic Therapy: An Updated Review Open
Photodynamic therapy has emerged as an effective therapeutic alternative to treat oncological, cardiovascular, dermatological, infectious, and ophthalmic diseases. Photodynamic therapy combines the action of a photosensitizer with light in…
View article: Effectiveness of ZnPc and of an amine derivative to inactivate Glioblastoma cells by Photodynamic Therapy: an in vitro comparative study
Effectiveness of ZnPc and of an amine derivative to inactivate Glioblastoma cells by Photodynamic Therapy: an in vitro comparative study Open
Glioblastoma multiforme is considered to be one of the most aggressive types of tumors of the central nervous system, with a poor prognosis and short survival periods of ~ one year. The current protocol for glioblastoma treatment includes …